Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive financial results for the quarter ended June 30, 2024. The company’s revenue surged by 9.7% quarter-on-quarter (QoQ), reaching ₹5,886 million. This growth reflects a solid 1.8% increase year-on-year (YoY), underlining Glenmark Life Sciences’ strong performance amidst challenging […]
Ami Organics Limited, a global leader in manufacturing advanced pharmaceutical intermediates and specialty chemicals, has signed a definitive agreement with Fermion, a subsidiary of Orion Corporation, Finland. This agreement marks the addition of two more advanced pharmaceutical intermediates to the company’s manufacturing portfolio for Fermion. The intermediates, to be produced under this agreement, will be […]
